GlobalBio Inc Profile last edited on: 1/29/2024
CAGE: 753D1
UEI: THWFM1981LG7
Business Identifier: Therapeutic antibody engineering 
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 04
County: Norfolk
Congr. District: 04
County: Norfolk
Public Profile
Working in the field of Therapeutic Antibody Engineering, GlobalBio, Inc was founded to meet the increasing demand for developing faster and more efficient methods for discovery and optimization of antibodies for therapeutic settings. Principals of the firm offer: Technical advice and consulting services to facilitate and streamline antibody engineering processes. Development and commercialization of computational tools to assist in the design and engineering of therapeutic antibodies. Humanization and developability enhancement services to optimize antibodies for therapeutic settings.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
1-4Revenue Range
Less than .5MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
N/AAwards Distribution by Agency
Most Recent SBIR Projects
| Year | Phase | Agency | Total Amount | |
|---|---|---|---|---|
| 2015 | 1 | NSF | $172,987 | |
| Project Title: Implementation of an in Silico Antibody Engineering Environment to engineer therapeutic antibodies | ||||
Key People / Management
Juan Carlos Almagro -- Founder and Presidwnt
Company News
There are no news available.
